Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Inventory (2016 - 2025)

Historic Inventory for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to $11.0 million.

  • Vanda Pharmaceuticals' Inventory rose 1584.15% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.0 million, marking a year-over-year increase of 1584.15%. This contributed to the annual value of $11.0 million for FY2025, which is 1584.15% up from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Inventory stood at $11.0 million for Q4 2025, which was up 1584.15% from $10.0 million recorded in Q3 2025.
  • Vanda Pharmaceuticals' Inventory's 5-year high stood at $11.5 million during Q4 2022, with a 5-year trough of $6.3 million in Q1 2021.
  • Its 5-year average for Inventory is $9.7 million, with a median of $10.0 million in 2024.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Inventory surged by 9455.19% in 2021, and later crashed by 1118.36% in 2023.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Inventory stood at $8.3 million in 2021, then soared by 39.24% to $11.5 million in 2022, then fell by 11.18% to $10.2 million in 2023, then dropped by 6.78% to $9.5 million in 2024, then increased by 15.84% to $11.0 million in 2025.
  • Its Inventory was $11.0 million in Q4 2025, compared to $10.0 million in Q3 2025 and $10.4 million in Q2 2025.